NCT07183813

Brief Summary

The aim of this study is to evaluate the effects and safety of acupuncture on anxiety and/or depression among patients with breast cancer.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
360

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Sep 2025Dec 2026

First Submitted

Initial submission to the registry

September 14, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 19, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

September 24, 2025

Status Verified

September 1, 2025

Enrollment Period

12 months

First QC Date

September 14, 2025

Last Update Submit

September 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The change from baseline in the total score of Hospital Anxiety and Depression Scale (HADS).

    The total score of HADS ranges from 0 to 42, with higher scores indicating greater anxiety and depression.

    week 8

Secondary Outcomes (11)

  • The change from baseline in the total score of HADS.

    weeks 4, 12, 16 and 20

  • The change from baseline in the score of HADS-A and HADS-D

    weeks 4, 8, 12, 16 and 20

  • Proportion of participants with a total HADS score less than 15, an HADS-A score of less than or equal to 7, and an HADS-D score of less than or equal to 7

    weeks 4, 8, 12, 16 and 20

  • Change from baseline in Hamilton Depression Scale-14

    Week 4, 8 and 20

  • Change from baseline in Hamilton Depression Scale-17

    Week 4, 8 and 20

  • +6 more secondary outcomes

Other Outcomes (6)

  • Expectance assessment

    baseline

  • Assessment of belief in acupuncture

    baseline and week 8

  • Blinding assessment

    week 8

  • +3 more other outcomes

Study Arms (2)

Electroacupuncture group

EXPERIMENTAL

Acupoints:Bai Hui acupoint, An Mian acupoint, Shang Yin Tang acupoint, Tai Yang acupoint, Tian Shu acupoint, Zu SanLi acupoint, Tai Chong acupoint, Shen Men acupoint.

Device: Electroacupuncture group

Sham electroacupuncture (SEA) group

SHAM COMPARATOR

Acupoints: Bai Hui acupoint, An Mian acupoint, Shang Yin Tang acupoint, Tai Yang acupoint, Tian Shu acupoint, Zu San Li acupoint, Tai Chong acupoint, Shen Men acupoint.

Device: Sham electroacupuncture

Interventions

The needles will be inserted to 15-40mm in acupoints through adhesive pads. Needles will be lifted, thrusted and twirled gently for 3 times to achieve deqi sensation and manipulated every ten minutes during 30-minute maintenance. The electronic acupuncture apparatus will be connected to the bileteral Taiyang, Anmian and Baihui, with a continuous wave of 2 Hertz (Hz) and an electric current of 1-3 milliampere (mA). Participants receive acupuncture treatment three times a week in the first two weeks and twice a week in the last six weeks.

Electroacupuncture group

The needle will be inserted to 2-3mm in Bai Hui acupoint. For the remaining acupoints, needles will be inserted into the pad till reaching but without penetrating the skin. Needles will be lifted, thrusted and twirled gently for 3 times to simulate the effects of the needle tip penetrating the skin. The electronic acupuncture apparatus will be connected to the Baihui acupoint, Shang Yin Tang acupoint, and bilateral An Mian acupoints, with a continuous wave of 2 Hertz (Hz) and an electric current of 0.1-0.3 mA. In about 3-5 seconds, the electric current will be turned down. Participants receive acupuncture treatment three times a week in the first two weeks and twice a week in the last six weeks.

Sham electroacupuncture (SEA) group

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female, aged 18 to 70 years old;
  • Meeting the diagnostic criteria for breast cancer and at TMN I-III;
  • Having completed specialized active treatment for at least one month;
  • With an ECOG score of 0-2;
  • Mild to moderate anxiety and/or depression;
  • Voluntarily joining this study and signing the informed consent form.

You may not qualify if:

  • Starting to take or change the regimen of anti-anxiety and/or -depression disorder medication within one month before enrolment;
  • Received psychological intervention or physical therapy one month before enrolment or planning to use in the next 5 months;
  • With diagnosis of anxiety and/or depression disorder prior to the diagnosis of breast cancer;
  • Patients with suicidal tendencies, bipolar disorder and psychotic symptoms;
  • Patients with severe anxiety and/or depression;
  • Patients received acupuncture treatment within one month before enrolment;
  • Participating in other clinical studies on the treatment of anxiety and/or depression;
  • Combined with severe underlying diseases;
  • Patients with severe skin ulcers;
  • Pregnant or lactating patients;
  • Poor compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Beijing, China

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending physician

Study Record Dates

First Submitted

September 14, 2025

First Posted

September 19, 2025

Study Start

September 15, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

September 24, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Deidentified participant data and data dictionary will be available with publication until six months after publication. Formal request should be sent to puzhisun@163.com with a methodologically sound proposal. Researchers whose proposal has been approved will sign a data access agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The data will be available with publication until until six months after publication.
Access Criteria
Formal request should be sent to puzhisun@163.com with a methodologically sound proposal. Researchers whose proposal has been approved. Researchers whose proposal has been approved will sign a data access agreement.

Locations